NEW YORK, Dec. 26, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Eargo, Inc. (NASDAQ: EAR)'s sale to an affiliate of Patient Square Capital for $2.55 per share in cash. If you are an Eargo shareholder, click here to learn more about your rights and options.
ImmunoGen, Inc. (NASDAQ: IMGN)'s sale to AbbVie Inc. for $31.26 per share in cash. If you are an ImmunoGen shareholder, click here to learn more about your rights and options.
Codorus Valley Bancorp, Inc. (NASDAQ: CVLY)'s sale to Orrstown Financial Services, Inc. for 0.875 shares of Orrstown common stock for each share of Codorus common stock. Upon closing of the proposed transaction, Codorus shareholders will own approximately 44% of the outstanding shares of the combined company. If you are a Codorus shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
SOURCE Halper Sadeh LLP
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article